London-based technology firm Provexis has signed licensing deals for Fruitflow, its patented tomato extract, with Coca-Cola and Unilever. Fruitflow has been shown to reduce the build-up of the blood platelets responsible for blood clots, the trigger for heart attacks and strokes.